Business

On a significant day for modern medicine, the Food and Drug Administration (FDA) gave the green light to Bristol Myers Squibb’s revolutionary schizophrenia medication, Cobenfy. This landmark approval marks the introduction of the first new class of treatment for schizophrenia in over seventy years, a notable achievement that could reshape the treatment landscape for individuals
0 Comments
The landscape of sports broadcasting is evolving rapidly, particularly within the realms of the NBA and NHL. As traditional pay-TV subscriptions decline, teams are seeking innovative ways to keep fans engaged and meet their viewing needs. Recently, Denver has been at the forefront of this shift, thanks to a new partnership between Kroenke Sports &
0 Comments
The current state of the U.S. automotive market paints a challenging picture as we move beyond the third quarter of 2024. Various factors contribute to this scenario, including economic uncertainties, political instability, rising interest rates, and historically high vehicle prices. As delineated by industry pioneers like Cox Automotive and Edmunds.com, the forecast suggests a considerable
0 Comments
The U.S. Department of Justice (DOJ) has unleashed a formidable antitrust lawsuit against Visa, the world’s largest payments network. Accusations suggest that Visa has maintained an illicit monopoly over the debit payment sector by erecting “exclusionary” agreements that inhibit competition and stifle innovation from upstart firms. This lawsuit epitomizes the increasing scrutiny of monopolistic practices
0 Comments
The landscape of airline loyalty programs is undergoing a significant transformation, highlighted by American Airlines’ negotiations to establish Citigroup as its exclusive credit card partner. Previously aligned with Barclays since the 2013 acquisition of US Airways, American Airlines is now seeking to consolidate its financial partnerships in a bid to maximize the profitability of its
0 Comments
In a surprising move, Ted Colbert, the head of Boeing’s defense unit, has departed from the company, as announced by CEO Kelly Ortberg. This abrupt change marks Ortberg’s first significant leadership alteration since he assumed his role in early August. Effective immediately, Colbert’s exit underscores the ongoing challenges faced by Boeing and highlights the urgency
0 Comments
In a bold move to tackle the rising costs associated with insulin—a life-saving medication for millions of Americans with diabetes—the Federal Trade Commission (FTC) has initiated a lawsuit against three major Pharmacy Benefit Managers (PBMs): Optum Rx, Caremark, and Express Scripts. These companies play a crucial role in the intricate web of drug pricing and
0 Comments